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Abstract  
 
Mechanism of renal fibrosis leading to end stage kidney remains still a challenge of 
interest in humans. The pathogenesis of chronic kidney disease is characterized by 
progressive loss of kidney function and fibrosis. The mechanism of epithelial–
mesenchymal transition (EMT) has been predominantly studied in in vitro studies, and we 
previously demonstrated the EMT of tubular epithelial cells in dogs. In this study, we 
examined and quantified the modifications of cadherin–catenin complex by 
immunohistochemistry of E-cadherin and β-catenin and the mesenchymal marker vimentin 
in 25 dogs with three different spontaneous inflammatory renal diseases. Results showed 
a significant down-expression of levels of E-cadherin and β-catenin directly correlated with 
the tubular–interstitial damage (TID). In TID grades 2 and 3, E-cadherin expression was 
significantly reduced (p<0.001). β-catenin expression was overall similar to E-cadherin. 
The mesenchymal associated protein, vimentin, was de novo identified in tubules within 
areas of inflammation. In this work, we identified the loss of cadherin or catenin expression 
as a progressive mechanism in tubulo-interstitial fibrosis, which allows dissociation of 
structural integrity of renal epithelia and loss of epithelial polarity. The dog might result 
more significant as model for new therapies. 
 
Keywords Adhesion molecule, Canine, Fibrosis 
 
 
Introduction 
 
By definition, epithelial–mesenchymal transition (EMT) is a phenotypic conversion of 
epithelial cells, leading to the loss of epithelial cell–cell-basement membrane contacts, 
structural–functional polarity, and acquisition of a fibroblastic phenotype [23]. A number of 
steps appear necessary to complete the process of EMT. Loss of the epithelial phenotype 
and disruption of adhesion molecules is the first phase of EMT, reported in several types 
of pathological processes: tumors, embryogenesis, and organ fibrosis [2, 15, 16, 21, 22]. 
Emerging evidence has established EMT as one of the major mechanism of renal fibrosis 
in human and other species [14]. In the latest studies, the authors showed that tubulo-
interstitial damage (TID) is characterized by loss of differentiated epithelial cells and 
activation of mesenchymal cells (renal fibroblasts) leading to renal fibrosis [27]. Tubular 
epithelial cells (TECs) undergo phenotypic change as demonstrated by de novo vimentin 
expression and loss of cytokeratin during chronic renal disease. While, under normal 
circumstances, the TECs are attached to each other and to the basement membrane 
through specialized junctional complexes that include molecules such as cadherin and 
catenin, during the injury, epithelial cells lose the polarity and the mechanisms of adhesion 
[18, 20]. These processes of cellular injury and detachment lead to the release of 
cytokines, different inflammatory mediators, and the recruitment of leukocytes to the site of 
injury. These inflammatory processes may both contribute to the injury and play a role in 
the repair mechanism that follows the injury [6, 7]. 
Canine renal pathology represents a good model for the examination of changes in the 
tubulo-interstitial compartment. In renal biopsies, early histomorphological signs of 
interstitial fibrosis in dogs are associated with an unfavorable prognosis, even if routine 
clinical parameters still indicate a compensated kidney function. We have recently 
demonstrated the similarity of the renal canine model to human, showing that the number 
of TECs undergoing EMT features is associated with the degree of TID [1]. The aim of the 
current study was to examine in the same distribution of damage the regulation of 
adherens junction complex (E-cadherin and β-catenin) in TECs. Numerous recent studies 
have shown that cellular adhesion molecules and their associated proteins may be critical 
early target in renal fibrosis murine model and in human transplanted kidney [2, 20]. To 
study the origin of the EMT, we focused our attention on the potential mechanisms of 
TECs activation in dogs with different types of spontaneous glomerular disease and 
associated tubulo-interstitial damage. We postulated that E-cadherin and β-catenin are key 
molecules in tubular EMT, and loss of expression of both markers is relevant in 
development of kidney fibrosis, through tubular EMT. 
 
Materials and methods 
 
We collected open renal specimens from 25 dogs who were examined and diagnosed with 
renal disease in the Department of Pathology, University of Turin in 2007. Disease 
categories were based on histological, immunofluorescent, and ultrastructural 
examination, and the diagnosis were given using the criteria of the WHO classification of 
glomerular diseases. The following groups were included in this study: membranous 
glomerulonephritis (6), membranoproliferative glomerulonephritis (13), and minimal 
change disease (6). Clinical parameters (plasma creatinine and proteinuria) were obtained 
at the time of collection (see Table 1). 
 
Histological examination 
Renal samples were fixed in 10% neutral buffered formalin, and sections were cut at 3 µm 
in thickness and routinely stained. On Masson’s Trichrome staining, interstitial fibrosis and 
inflammation were assessed at ×200 magnification and scored as follow: normal tubulo-
interstitium (TID grade=0), mild tubular atrophy, and interstitial edema or fibrosis affecting 
up to 25% of the field of view (TID grade=1); moderate tubulo-interstitial fibrosis affecting 
25–50% of a given field (TID grade=2); severe tubulo-interstitial fibrosis >50% of a field 
(TID grade=3). 
 
Immunofluorescence 
For immunofluorescence, unfixed renal tissue was OCTembedded, snap-frozen in liquid 
nitrogen, and stored at −80°C. Fluorescein Isothiocyanate-labeled anti-goat IgA, IgG, IgM, 
and complement C3 antibodies specific for the dog (Bethyl Laboratories INC., 
Montgomery, AL, USA) were used. Primary antibodies were omitted as negative controls. 
 
Immunohistochemistry 
An immunohistochemical panel was performed to assess the changes to the TECs. The 
following antibodies were used in this work: antihuman E-cadherin (clone 36, Transduction 
Laboratories, Lexington, KY, USA), antimouse β-catenin (clone 14, Transduction 
Laboratories) and anti vimentin (Dako, Glostrup, Denmark). For the immunostaining, 
paraffin kidney sections (4 µm) were dewaxed and rehydrated, and antigen retrieval was 
performed by microwave exposure for 3 min (three times) in a citrate buffer (pH 6.0) at 600 
W. When the temperature of the buffer reached room temperature, the slides were rinsed 
in phosphate-buffered saline (PBS) and incubated with hydrogen peroxide (H2O2) 3% in 
methanol for 15 min to block endogenous peroxidase activity. After rinsing in PBS, 
background staining was blocked using PBS added of 10% bovine serum albumin (BSA, 
Sigma–Aldrich, St. Louis, MO, USA) for 20 min. The sections were then incubated with the 
primary antibody diluted in PBS 10% BSA for 60 min. Anti E-cadherin and anti β-catenin 
were diluted 1:70, anti vimentin 1:50 in PBS 10% BSA. After two washings with PBS, the 
sections were incubated with the secondary antibody provided by a commercial kit (Real 
EnVision™ peroxidase Detection System, Dako) for 30 min then washed twice in PBS; the 
reaction was developed with the DAB solution provided by the kit, washed in tap water, 
and counterstained with hematoxylin and PAS. Normal mammary gland was also used as 
positive control of the immune reaction for E-cadherin and β-catenin. We tested normal 
canine kidney tissue to quantify the expression of E-cadherin and β-catenin in TECs, and 
we used normal mammary gland for comparison. Expression of both markers in control 
dogs results to be mostly total in cytoplasm and membrane of TECs. 
 
Double immunohistochemistry 
Vimentin and β-catenin double antigen-immunoperoxidase labeling was performed using a 
commercial kit (Vector Laboratories, Burlingame, CA, USA), according to manufacturer’s 
instructions. Peroxidase activity was demonstrated firstly by DAB + Ni2+ (grey to black 
chromogen reaction) for Vimentin and secondly by 3-amino-9-ethylcarbazole (AEC, red 
chromogen reaction) for β-catenin.  
 
Quantification of immunohistochemistry and statistical analysis 
Immunohistochemical staining was assessed with respect to its localization and its 
intensity. E-cadherin and β-catenin immunoreactivity was classified as membranous 
(localized to cell–cell boundaries) or cytoplasmic (uniformly distributed through the 
cytoplasm, with no recognizable distinction between membrane and cytoplasm). 
Quantification of E-cadherin and β-catenin expression in each case was graded according 
to loss in TEC of immune reaction for the two markers. Loss of cytoplasmic staining of 
adhesion molecules (E-cadherin and β-catenin) was assessed by counting the percentage 
of stain-negative cells per HPFs. 
For each case examined, analysis was performed by counting ten fields (×200), focusing 
on TECs. Expression of cytoplasmic staining for mesenchymal marker (vimentin) 
was evaluated by counting the percentage of positively stained TEC per HPFs. The 
staining intensity, based on the area of distribution, was also assigned from 0% to 100%. 
The semiquantitative evaluation of immunostaining was evaluated by an electronic image 
analysis system (Adobe Photoshop CS3). Images were digitalized using a video camera 
connected to a single microscope and to a computer equipped with a frame grabber 
(Neotech Ltd, Eastleigh Hampshire, UK). In order to detect a possible relationship between 
the two percentages of the variables (E-cadherin or β-catenin and area), a scatter plot was 
used, grouping their values according to the nominal variable TID. Furthermore, the 
product of the percentage of the values for the intensity and the area was used to increase 
the sensitivity of the data. 
Data are presented as means ± SD. Analysis of variance (ANOVA) was performed, and 
the six comparisons among the mean values of the pairs were performed using the 
Bonferroni Multiple Comparison Test. Statistical analyses were performed with GraphPad-
InStat software (GraphPad Software, San Diego, CA, USA). 
 
Results 
Tubulo-interstitial damage was a common finding in membranous and 
membranoproliferative glomerulonephritis (Fig. 1). In minimal change disease, only 
minimal areas of inflammation and fibrosis were detected (TID grade 1). All three grades of 
TID were present among the samples examined. For each case, the quantitative analysis 
data corresponding to the grade of TID are summarized in Table 2. 
Renal samples, independent of the diagnosis, showed a variable intensity of positive 
immunostaining in the TECs for E-cadherin and β-catenin. 
 
Expression of E-cadherin 
Uniform, strong membranous, and cytoplasmatic E-cadherin staining was localized in 
TECs in the controls (87.7±2.0 product, see Fig. 2a). In TID grade 1, E-cadherin 
immunoreactivity was minimally reduced when compared to normal TECs (62.2±2.5 
product). In TID grades 2 (33.7±2.0) and 3 (12.5±4.0, see Fig. 2b and c), E-cadherin 
expression was significantly reduced. Distribution in TECs, independently of the disease, 
was heterogeneous or negative compared with that in normal tubular epithelium and was 
characterized by patterns with variable degrees of membrane and cytoplasmic staining. 
This expression was preserved in the intact tubules next to the areas of inflammation. 
Table 1 summarizes the relationship between E-cadherin expression and the TID grade. 
E-cadherin expression in all cases examined significantly correlated with the histological 
grade (p<0.001). 
 
Expression of β-catenin 
Normal TECs showed expression of β-catenin; the signal was recorded not only more 
intensely at cell junctions, but also diffusely in the cytoplasm (92.5±2.0 product, see Fig. 
2d). The β-catenin expression was similar to E-cadherin in all lesions examined. 
Expression of β-catenin was reduced in TID grade 1 (58.8±2.2 product, see Fig. 2e) 
compared to normal TECs (p<0.001). Scattered positive TECs in the TID grade 3 showed 
an exclusively granular cytoplasmic pattern (see Fig. 2f). Tubules next to the inflammation 
retained the cytoplasmic and membrane localization of catenin. Nuclear staining was also 
observed in some cells. Data are shown in Table 1. 
 Expression of vimentin 
No tubular expression of vimentin was detected in control dogs (Figs. 3, 4). De novo 
expression of vimentin marker was identified in tubular epithelial cells in different 
proportion, statistically correlated with the TID grade (p<0.01). More intense vimentin 
expression was restricted to areas of tubular damage, and concomitant expression of 
vimentin and β-catenin was recorded in the same tubular cross sections in double 
immunohistochemistry (see Fig. 5a and b). However, the expression of vimentin marker 
was demonstrated in TECs of degenerate atrophic tubules within areas of inflammation 
(48.2±10.3 TECs/field in TID grade 3). Both intact tubules closed to the inflammation 
showed vimentin staining. Quantification of the percentage of tubules expressing vimentin 
marker is shown in Table 1. 
 
Examination of PAS-vimentin immunohistochemistry 
showed a thickening of tubular basement membrane correlated with tubules vimentin 
positive; no ruptures were identified (see Fig. 6). 
 
Statistical results 
The scatter plot used to detect the relationship between the two variables percentages of 
E-cadherin or β-catenin, and area showed that the four clusters of TID were homogeneous 
and evidenced a systematic difference between them (see Figs. 3 and 4). Moreover, the 
two variables were strongly correlated; so, a new variable, the product of the mentioned 
ones, was considered for the statistical analysis. ANOVA revealed that all the differences 
were highly significant (p<0.001). Therefore, the six comparisons among the mean values 
of the pairs were performed using the Bonferroni Multiple Comparison Test, and the 
differences were again highly significant (p<0.001). 
The last analysis was the modelization of the composed variable product with respect to 
TID according to a linear model. Both the line plot and the statistical indices p value and 
R2 encourage to predict the variable product of Ecadherin or β-catenin and area according 
to a more suitable model, a quadratic one (see Figs. 3 and 4). 
 
Discussion 
 
In this study, we sought to determine whether the EMT process was related to down-
expression of E-cadherin and β-catenin and if this correlated with the different grades of 
TID in the most common spontaneous canine renal diseases. 
The E-cadherin–catenin complex plays a fundamental role in the construction of epithelia. 
Cadherins comprise a family of calcium-dependent cell–cell adhesion proteins that play 
important role in embryonic development and maintenance of normal tissue architecture 
[5, 6, 28]. The cadherin–catenin complex binds to the cytoskeletal components, including 
actin bundles, and the linkage in this complex is crucial for E-cadherin to function normally 
[17]. 
The predominant epithelial isoform, E-cadherin, localizes in the lateral membrane of 
differentiated epithelia, providing the structural foundation for adherens junctions [18]. In 
fact, they not only function as static structural components of adherens junctions but they, 
along with some of their associated molecules, also play critical role in regulating cell-
signaling pathways [3, 19, 26]. Likewise, the inflammatory processes may either contribute 
to the initial injury or occur as a consequence of the cellular injury involving specific 
changes in the expression and function of cell adhesion molecules that are necessary for 
the migration, attachment, and activation of leukocytes [26]. 
Cadherin–catenin complex alterations have been studied in the development of 
carcinogenesis model and to understand the mechanism of epithelial mesenchymal 
transition in the fibrotic process [2, 4]. Few papers demonstrate that changes in cadherin 
expression are fundamentals to the process of EMT and cellular motility [19, 24]. In the 
human adult kidney, the cadherins are differently expressed in various segments of the 
nephron. In a study of mouse kidney, Piepenhagen and Nelson [25] showed that E-
cadherin is abundantly expressed in most segments of the nephron, including the proximal 
tubules. Cho and colleagues [8] also reported that E-cadherin is present in the proximal 
and distal tubules of newborn mice. In the present experiment, normal kidney from control 
dogs showed cytoplasmatic and membrane expression of both adhesion markers in all 
segments of the nephron.  
The immunohistochemical profiles of E-cadherin and β-catenin observed in this study 
result not associated with the glomerular lesions; no correlation was found among the 
different classes of disease. On the contrary, the reduction in cadherin and catenin 
expression was strictly related to the TID: a statistical significant association (p<0.01) was 
found that correlated with the different evolution of TID. 
Data on the expression of β-catenin in renal specimens are similar for E-cadherin with a 
similar frequency of alterations, and we also identified the presence on nuclear expression 
of catenin. Different in vitro studies have demonstrated that down-expression of E-
cadherin is related with translocation of β-catenin from the membrane leading to the 
cytoplasm and then into the nucleus. This translocation suggests the loss of epithelial 
polarity and integrity [9]. β-Catenin has a dual role in the EMT: it enhances cell–cell 
adhesion when bound to cadherin complexes in adherens junctions and also functions as 
a transcriptional co-activator upon entry into the nucleus [7, 11, 13]. The results obtained 
in this experiment evoke an interesting speculation: downexpression of cadherin–catenin 
system in TECs is a necessary step for transdifferentiation of these cells into cells 
acquiring mesenchymal features. The entire process requires alterations in morphology, 
cellular architecture, and adhesion capacity [10, 12, 31]. TECs under normal conditions 
are tightly connected to each other to form an integrated epithelial sheet through cell 
adhesion mechanisms fundamental for their functions, and no mesenchymal features are 
evident in TECs (vimentin expression in control dogs: 0.0±0.0). As disease progresses, 
epithelial tubular markers largely disappeared, and coexpression of vimentin and epithelial 
markers in TECs becomes evident (β-catenin expression in TID grade 3: 12.0±4.4). 
Positivity for mesenchymal antigen and loss of adhesion junction properties were mainly 
detected in well-preserved tubular structures without signs of tubular basement membrane 
disruption or possible cell migration into the interstitium, as demonstrated by PAS 
counterstain. 
To investigate this mechanism, we performed double immunohistochemistry for vimentin 
and β-catenin. This technique permits to identify the colocalization of both markers and 
define the process as step by step due to the progressive modification in the same tubular 
cross section. 
This work confirms that loss of cadherin or catenin expression is an early mechanism in 
tubulo-interstitial fibrosis, which allows dissociation of structural integrity of renal epithelia 
and loss of epithelial polarity. To enable migration of single epithelial cells, the strong cell–
cell adhesion, a feature of epithelial cells, has to be reduced. Therefore, the reduction of 
cellular adhesion is associated with epithelial dedifferentiation mechanism. EMT is easily 
started by a combination of cytokines associated with proteolytic digestion of basement 
membranes upon which epithelia reside [10, 29, 30]. The canine renal model offers 
different advantages in the study for the role of adhesion molecules and the EMT 
mechanism in kidney, such as the development of spontaneous diseases, the slow 
progression of the disease, and overall, the similarity of inflammatory lesions in the canine 
kidney to humans. 
In summary, we could describe the process of EMT in different events involving: loss of 
adhesion properties (loss of catenin and cadherin expression) and de novo expression of 
mesenchymal features (vimentin positive reaction in TECs). This study provides the first 
evidence that TECs can undergo phenotypic change toward a mesenchymal expression 
during progressive renal fibrosis in canine glomerulonephritis on the basis of de novo 
vimentin expression and down-expression of epithelial markers of junction. While down-
regulation of cadherins is well described in cultured cells and murine model, it still remains 
to be shown whether such events occur in spontaneous renal pathology in human [28, 29, 
32]. On the base of this experimental study, the dog becomes an important model for 
further investigations, especially for the expression of TGF-β, a major regulator of EMT 
and cadherins expression in the TECs. 
 
 
 
 
 
 
 Fig. 1 a Granular pattern deposition along the glomerular basement membrane associated with mesangial 
distribution. (FITC-anti-goat IgG, ×400). b Diffuse, intense granular deposits along the glomerular basement 
membrane. (FITC-anti-goat IgG, ×400). c Deposition along the basement membrane and in the mesangium 
in a membranoproliferative glomerulonephritis (AFOG, ×400). d Diffuse thickening of glomerular basement 
membrane due to intramembranous deposition in a membranous glomerulonephritis (AFOG, ×400) 
 
 Fig. 2 a Normal E-cadherin cytoplasm and membrane expression in control kidney (×200). b Progressive lost 
of cadherin expression in tubular epithelial cells (arrow) and tubules with normal expression (asterisk) in TID 
grade 2 (×400). c Negative staining of E-cadherin in multifocal tubules (arrow) in TID grade 3 (×100). d β-
catenin intensely stained membrane of epithelial tubular cells in control kidney (×200). e Progressive lost of 
β-catenin expression in scattered epithelial cells in TID grade 1 (×200). f Lost of β-catenin expression evident 
in tubular cross sections (arrow) and tubules with normal expression (asterisk) in TID grade 3 (×200) 
 
 Fig. 3 Left scatter plot to detect the relationship between the two variables percentages of E-cadherin and 
area. Right modelization of the composed variable product for E-cadherin with respect to TID 
 
 
 
Fig. 4 Left scatter plot to detect the relationship between the two variables percentages of β-catenin and 
Area. Right modelization of the composed variable product for β-catenin with respect to TID 
 
 
 Fig. 5 a, b Scattered epithelial tubular cells β-catenin positive stained in red and several epithelial tubular 
cells vimentin positive stained in black in same tubular cross section (arrow) in TID grade 2 (double 
immunohistochemistry, a ×400, b ×600) 
 
 
 
Fig. 6 Down-expression of β-catenin associated with tubular basement membrane thickening, no sign of 
rupture (Vimentin-PAS counterstained, ×200) 
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